ASTANA, Kazakhstan, October 1. President of Kazakhstan Kassym-Jomart Tokayev has met with member of the board, head of the pharmaceutical department of Bayer AG Stefan Oelrich in Berlin, Trend reports.
During the meeting, prospects for cooperation in the fields of healthcare, sustainable agriculture and scientific research were discussed.
Tokayev noted Kazakhstan's interest in accessing Bayer's latest medical products, as well as in opening laboratories and implementing joint research projects.
Tokayev said that Kazakhstan is actively working on the development of a biotechnology cluster. He announced the creation of a national biopharmaceutical holding QazBioPharm, designed to deploy and implement developments in these industries.
The topic of discussion also included potential measures to simplify procedures for importing new medicines into Kazakhstan.
According to Tokayev, of particular interest is the creation of production facilities for the production of fertilizers, pesticides and other biochemicals used in agriculture in Kazakhstan.
Bayer AG is an international concern specializing in life sciences solutions for healthcare and agriculture.